Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level
The pharmaceutical industry is plagued with long, costly development and high risk. Therefore, a company's effective management and optimisation of a portfolio of projects is critical for success. Project metrics such as the probability of success enable modelling of a company's pipeline a...
Gespeichert in:
| Veröffentlicht in: | Pharmaceutical statistics : the journal of the pharmaceutical industry 2024-05, Vol.23 (3), p.429-438 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 438 |
|---|---|
| container_issue | 3 |
| container_start_page | 429 |
| container_title | Pharmaceutical statistics : the journal of the pharmaceutical industry |
| container_volume | 23 |
| creator | Wiklund, Stig‐Johan Thorn, Katharine Götte, Heiko Hacquoil, Kimberley Saint‐Hilary, Gaëlle Carlton, Alex |
| description | The pharmaceutical industry is plagued with long, costly development and high risk. Therefore, a company's effective management and optimisation of a portfolio of projects is critical for success. Project metrics such as the probability of success enable modelling of a company's pipeline accounting for the high uncertainty inherent within the industry. Making portfolio decisions inherently involves managing risk, and statisticians are ideally positioned to champion not only the derivation of metrics for individual projects, but also advocate decision‐making at a broader portfolio level. This article aims to examine the existing different portfolio decision‐making approaches and to suggest opportunities for statisticians to add value in terms of introducing probabilistic thinking, quantitative decision‐making, and increasingly advanced methodologies. |
| doi_str_mv | 10.1002/pst.2361 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929027942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3056525067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3101-1681fac309c09c41d4f356b289f3502286532f82dff260fc8b83111c28e562183</originalsourceid><addsrcrecordid>eNp1kcFqFTEUhoMotlbBJ5CAGze35pzcmZtxJ0WrUKhgXYdM5kRTc5PpJNNyd-667TP6JGZsrSAIgRPIx5fz8zP2HMQhCIGvx1wOUbbwgO1DI7sVtIAP7-9ivcee5HwuBGxU1zxme1IhoOrUPrs-Tj5-5T3tUhz4OKXe9D74suPJ8TxbSzm_4afjmKYyR188Ze7SxHMxxefirTcx85K4jy7MFC3xi9nE4pf3S-IDWZ99ij9_3GzN9-UrU3j5RnwRuhR84oEuKTxlj5wJmZ7dzQP25f27s6MPq5PT449Hb09WVoKAGkaBM1aKztazhmHtZNP2NUudAlG1jUSncHAOW-Gs6pUEAIuKmhZByQP26tZbo17MlIve-mwpBBMpzVljh53ATbfGir78Bz1P8xTrdlqKpm2wEe3mr9BOKeeJnB4nvzXTToPQSzm6lqOXcir64k4491sa7sE_bVRgdQtc-UC7_4r0p89nv4W_AHo7mv4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3056525067</pqid></control><display><type>article</type><title>Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wiklund, Stig‐Johan ; Thorn, Katharine ; Götte, Heiko ; Hacquoil, Kimberley ; Saint‐Hilary, Gaëlle ; Carlton, Alex</creator><creatorcontrib>Wiklund, Stig‐Johan ; Thorn, Katharine ; Götte, Heiko ; Hacquoil, Kimberley ; Saint‐Hilary, Gaëlle ; Carlton, Alex ; European Special Interest Group on Quantitative Decision-Making ; the European Special Interest Group on Quantitative Decision‐Making</creatorcontrib><description>The pharmaceutical industry is plagued with long, costly development and high risk. Therefore, a company's effective management and optimisation of a portfolio of projects is critical for success. Project metrics such as the probability of success enable modelling of a company's pipeline accounting for the high uncertainty inherent within the industry. Making portfolio decisions inherently involves managing risk, and statisticians are ideally positioned to champion not only the derivation of metrics for individual projects, but also advocate decision‐making at a broader portfolio level. This article aims to examine the existing different portfolio decision‐making approaches and to suggest opportunities for statisticians to add value in terms of introducing probabilistic thinking, quantitative decision‐making, and increasingly advanced methodologies.</description><identifier>ISSN: 1539-1604</identifier><identifier>EISSN: 1539-1612</identifier><identifier>DOI: 10.1002/pst.2361</identifier><identifier>PMID: 38212898</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Inc</publisher><subject>drug development ; optimisation ; portfolio management ; project metrics</subject><ispartof>Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-05, Vol.23 (3), p.429-438</ispartof><rights>2024 John Wiley & Sons Ltd.</rights><rights>2024 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3101-1681fac309c09c41d4f356b289f3502286532f82dff260fc8b83111c28e562183</cites><orcidid>0000-0002-6305-4466 ; 0000-0003-2128-5503 ; 0000-0003-1643-3348 ; 0000-0002-3940-2459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpst.2361$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpst.2361$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38212898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiklund, Stig‐Johan</creatorcontrib><creatorcontrib>Thorn, Katharine</creatorcontrib><creatorcontrib>Götte, Heiko</creatorcontrib><creatorcontrib>Hacquoil, Kimberley</creatorcontrib><creatorcontrib>Saint‐Hilary, Gaëlle</creatorcontrib><creatorcontrib>Carlton, Alex</creatorcontrib><creatorcontrib>European Special Interest Group on Quantitative Decision-Making</creatorcontrib><creatorcontrib>the European Special Interest Group on Quantitative Decision‐Making</creatorcontrib><title>Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level</title><title>Pharmaceutical statistics : the journal of the pharmaceutical industry</title><addtitle>Pharm Stat</addtitle><description>The pharmaceutical industry is plagued with long, costly development and high risk. Therefore, a company's effective management and optimisation of a portfolio of projects is critical for success. Project metrics such as the probability of success enable modelling of a company's pipeline accounting for the high uncertainty inherent within the industry. Making portfolio decisions inherently involves managing risk, and statisticians are ideally positioned to champion not only the derivation of metrics for individual projects, but also advocate decision‐making at a broader portfolio level. This article aims to examine the existing different portfolio decision‐making approaches and to suggest opportunities for statisticians to add value in terms of introducing probabilistic thinking, quantitative decision‐making, and increasingly advanced methodologies.</description><subject>drug development</subject><subject>optimisation</subject><subject>portfolio management</subject><subject>project metrics</subject><issn>1539-1604</issn><issn>1539-1612</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kcFqFTEUhoMotlbBJ5CAGze35pzcmZtxJ0WrUKhgXYdM5kRTc5PpJNNyd-667TP6JGZsrSAIgRPIx5fz8zP2HMQhCIGvx1wOUbbwgO1DI7sVtIAP7-9ivcee5HwuBGxU1zxme1IhoOrUPrs-Tj5-5T3tUhz4OKXe9D74suPJ8TxbSzm_4afjmKYyR188Ze7SxHMxxefirTcx85K4jy7MFC3xi9nE4pf3S-IDWZ99ij9_3GzN9-UrU3j5RnwRuhR84oEuKTxlj5wJmZ7dzQP25f27s6MPq5PT449Hb09WVoKAGkaBM1aKztazhmHtZNP2NUudAlG1jUSncHAOW-Gs6pUEAIuKmhZByQP26tZbo17MlIve-mwpBBMpzVljh53ATbfGir78Bz1P8xTrdlqKpm2wEe3mr9BOKeeJnB4nvzXTToPQSzm6lqOXcir64k4491sa7sE_bVRgdQtc-UC7_4r0p89nv4W_AHo7mv4</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Wiklund, Stig‐Johan</creator><creator>Thorn, Katharine</creator><creator>Götte, Heiko</creator><creator>Hacquoil, Kimberley</creator><creator>Saint‐Hilary, Gaëlle</creator><creator>Carlton, Alex</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6305-4466</orcidid><orcidid>https://orcid.org/0000-0003-2128-5503</orcidid><orcidid>https://orcid.org/0000-0003-1643-3348</orcidid><orcidid>https://orcid.org/0000-0002-3940-2459</orcidid></search><sort><creationdate>202405</creationdate><title>Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level</title><author>Wiklund, Stig‐Johan ; Thorn, Katharine ; Götte, Heiko ; Hacquoil, Kimberley ; Saint‐Hilary, Gaëlle ; Carlton, Alex</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3101-1681fac309c09c41d4f356b289f3502286532f82dff260fc8b83111c28e562183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>drug development</topic><topic>optimisation</topic><topic>portfolio management</topic><topic>project metrics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiklund, Stig‐Johan</creatorcontrib><creatorcontrib>Thorn, Katharine</creatorcontrib><creatorcontrib>Götte, Heiko</creatorcontrib><creatorcontrib>Hacquoil, Kimberley</creatorcontrib><creatorcontrib>Saint‐Hilary, Gaëlle</creatorcontrib><creatorcontrib>Carlton, Alex</creatorcontrib><creatorcontrib>European Special Interest Group on Quantitative Decision-Making</creatorcontrib><creatorcontrib>the European Special Interest Group on Quantitative Decision‐Making</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical statistics : the journal of the pharmaceutical industry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiklund, Stig‐Johan</au><au>Thorn, Katharine</au><au>Götte, Heiko</au><au>Hacquoil, Kimberley</au><au>Saint‐Hilary, Gaëlle</au><au>Carlton, Alex</au><aucorp>European Special Interest Group on Quantitative Decision-Making</aucorp><aucorp>the European Special Interest Group on Quantitative Decision‐Making</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level</atitle><jtitle>Pharmaceutical statistics : the journal of the pharmaceutical industry</jtitle><addtitle>Pharm Stat</addtitle><date>2024-05</date><risdate>2024</risdate><volume>23</volume><issue>3</issue><spage>429</spage><epage>438</epage><pages>429-438</pages><issn>1539-1604</issn><eissn>1539-1612</eissn><abstract>The pharmaceutical industry is plagued with long, costly development and high risk. Therefore, a company's effective management and optimisation of a portfolio of projects is critical for success. Project metrics such as the probability of success enable modelling of a company's pipeline accounting for the high uncertainty inherent within the industry. Making portfolio decisions inherently involves managing risk, and statisticians are ideally positioned to champion not only the derivation of metrics for individual projects, but also advocate decision‐making at a broader portfolio level. This article aims to examine the existing different portfolio decision‐making approaches and to suggest opportunities for statisticians to add value in terms of introducing probabilistic thinking, quantitative decision‐making, and increasingly advanced methodologies.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Inc</pub><pmid>38212898</pmid><doi>10.1002/pst.2361</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-6305-4466</orcidid><orcidid>https://orcid.org/0000-0003-2128-5503</orcidid><orcidid>https://orcid.org/0000-0003-1643-3348</orcidid><orcidid>https://orcid.org/0000-0002-3940-2459</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1539-1604 |
| ispartof | Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-05, Vol.23 (3), p.429-438 |
| issn | 1539-1604 1539-1612 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2929027942 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | drug development optimisation portfolio management project metrics |
| title | Going beyond probability of success: Opportunities for statisticians to influence quantitative decision‐making at the portfolio level |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Going%20beyond%20probability%20of%20success:%20Opportunities%20for%20statisticians%20to%20influence%20quantitative%20decision%E2%80%90making%20at%20the%20portfolio%20level&rft.jtitle=Pharmaceutical%20statistics%20:%20the%20journal%20of%20the%20pharmaceutical%20industry&rft.au=Wiklund,%20Stig%E2%80%90Johan&rft.aucorp=European%20Special%20Interest%20Group%20on%20Quantitative%20Decision-Making&rft.date=2024-05&rft.volume=23&rft.issue=3&rft.spage=429&rft.epage=438&rft.pages=429-438&rft.issn=1539-1604&rft.eissn=1539-1612&rft_id=info:doi/10.1002/pst.2361&rft_dat=%3Cproquest_cross%3E3056525067%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3056525067&rft_id=info:pmid/38212898&rfr_iscdi=true |